The EU is expanding its number of Biosafety-Level 4 laboratories (BSL-4). BSL-4 labs are designed for research on the most dangerous pathogens and incorporate extensive safety features. Eight new facilities are under construction or planned and will join the six labs that currently operate in Britain, Germany, Sweden and France. The new labs are needed […]
India is an attractive location for the operations of not only the world’s largest drug companies, but mid-sized companies as well. To establish themselves in the country, many foreign firms have made acquisitions or set up small operations. Among the recent acquirers is Perrigo, which bought Vedants Drugs and Fine Chemicals this fall and plans […]
The World Health Organization estimates that the swine flu has claimed 6,250 lives. The Americas shows the highest rate of death with 4,512 people having died from the virus. In the US alone, new estimates from the Centers for Disease Control and Prevention put the total number of fatalities at 3,900. The spread of the […]
US sales of biologics increased 4.5% last year to about $46.5 billion, down from historical double-digit growth due to safety concerns and market saturation. Among the nine classes of biologics, the largest therapeutic class, with 35% of the market, remains monoclonal antibodies (mAbs). US sales of mAbs increased an estimated 13% in 2008, down from […]
Although prospects for the mining industry have improved from a year ago, its most recent gains remain precarious. Some observers assert that the demand for metals from China and other developing countries is returning and will remain strong, with the effects of the global economic slowdown having only temporary effect. Rio Tinto estimates that global […]
In the third quarter of 2009, revenues for IBO’s Laboratory Instrument Sales Index declined 3.0% to $4,405.53 million, while operating profit decreased 2.3% to $762.90 million. Operating margin slipped 10 basis points to 17.3% of sales. For the three companies (Oxford Instruments, Shimadzu and Tecan) that did not report earnings before this issue’s publication, modest […]
Cambridge, MA 11/9/09—Two months after hiring Thomas Weisel Partners to explore strategic alternatives for the company, including a sale (see IBO 9/15/09), Helicos BioSciences has announced that it is no longer pursuing such discussions due to improving prospects and market valuation. However, the company continues to work with Thomas Weisel on a long-term financing strategy. […]
Hillsboro, OR 11/3/09; Eindhoven, The Netherlands 11/3/09—FEI Company has sold its Phenom Scanning Electron Microscopy product line to Phenom-World BV for an undisclosed amount. Phenom-World was established November 3 and is a majority-owned subsidiary of NTS Group BV, FEI’s manufacturing and development partner for the Phenom. Phenom-World will be responsible for marketing, sales and distribution […]
Billerica, MA 11/9/09; Washington, DC 11/13/09—Bruker has announced two changes at the executive level. The company has appointed CFO Bill Knight to the newly created position of chief operating officer, effective February 1, 2010. “Over the past five years, Bill Knight has demonstrated strong financial and operational leadership at Bruker, and in his newly-created COO […]
Carlsbad, CA 11/10/09; Woburn, MA 11/10/09—Life Technologies has agreed to acquire BioTrove for an undisclosed amount. The purchase involves BioTrove’s OpenArray high-throughput gene expression and genotyping analysis system for PCR. Applied Biosystems and BioTrove have collaborated since 2007 (see IBO 11/30/07). “This acquisition and other enhancements recently made to our PCR offerings enable us to […]
Pay Invoice
Latest Blogs
-
Lab Tool Companies and Share Repurchases
October 30, 2025 4:15 pm
-
Precision Cell Systems: Bringing Companies Together to Share Resources
September 30, 2025 1:53 pm
-
August 28, 2025 1:28 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
